Time to buy local: war fuel price shocks reveal the folly of a long food supply chain 
Gold Prices Surge on U.S.-Iran Ceasefire Reports 
U.S. Praises Kurdistan's Role in Oil Markets Amid Iran War Fallout 
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation 
Citi Names Eric Farina and Rob Cascarino to Lead Global Infrastructure Financing Group 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Trump Tariffs Show Minimal Economic Impact but Boost Federal Revenue, Study Finds 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
9 Tips for Avoiding Tax Season Cyber Scams 
SpaceX IPO Filing Expected This Week as Valuation Could Surpass $75 Billion 
Asian Currencies Stay Muted as Dollar Holds Firm Amid Iran Uncertainty 
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets 
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now 
Gold Prices Climb as Middle East Ceasefire Talks Stir Market Optimism 
South Korea will invest 274.6 billion won in the bio-industry this year for 252 new R&D projects in the four fields of biopharmaceuticals, healthcare, biomaterials, and medical equipment in 2023.
According to South Korea’s Ministry of Trade, Industry and Energy, 94.8 billion won would be allocated to developing new medicines, microbiome analysis, and other biomanufacturing process technology.
Around 69.5 billion won will support the development of advanced medical appliances, and 30 billion won will be for developing state-of-the-art biomaterials.
The ministry added that beefing up support for biomaterials and other new fields of the sector would promote innovation.
